$AKTS 4 SEC Filings

Filed On	Filing
24 Sep 2026	Form 4: Czibere Akos, Chief Medical Officer Received 12,500 shares by exercise or conversion ($61.9K) · Sold 12,500 shares ($259K)
21 Jul 2026	Form 4: Herrmann Ken, Director Received 4,856 shares by exercise or conversion ($2.86K) · Sold 4,856 shares ($119K)
20 Jul 2026	Form 4: Herrmann Ken, Director Received 3,065 shares by exercise or conversion ($245) · Sold 3,065 shares ($77.3K)
10 Jul 2026	Form 4: Ron-Bigger Shulamit, Chief Operating Officer Received 50,000 shares by exercise or conversion ($183K) · Sold 50,000 shares ($1.39M)
10 Jul 2026	Form 4: Czibere Akos, Chief Medical Officer Received 50,000 shares by exercise or conversion ($248K) · Sold 50,000 shares ($1.39M)
16 Apr 2026	Form 4: Gormley Glenn, Director Granted 37,866 Stock Option (Right to Buy)
14 Jan 2026	Form 4: Foley Todd, Director Received 4,002,533 shares by conversion · Bought 232,870 shares ($4.19M)
14 Jan 2026	Form 4: Mpm Bioventures 2018, L.p., 10% owner and 7 others Received 8,805,578 shares by conversion · Bought 1,112,777 shares ($20M)
14 Jan 2026	Form 4: Gadicke Ansbert, 10% owner and 2 others Received 8,805,578 shares by conversion · Bought 1,112,777 shares ($20M)
12 Jan 2026	Form 4: EcoR1 Capital, Llc, Director and 1 other Received 2,602,247 shares by conversion · Bought 2,222,222 shares ($40M) · Acquired 1,051,412 Class A Common Stock (Derivative Conversion)
12 Jan 2026	Form 4: Vida Ventures II, Llc, 10% owner and 1 other Received 4,994,212 shares by conversion · Bought 835,000 shares ($15M)
12 Jan 2026	Form 4: Segal Lloyd Mitchell, Director Received 19,631 shares by conversion
12 Jan 2026	Form 4: Kim Helen Susan, Director Received 4,994,212 shares by conversion · Bought 835,000 shares ($15M)

Comments